Dr. Christopher John McCarthy, MD

Dr. McCarthy practices at St Luke's Hospital Quakertown Campus - Outpatient Respiratory Pft Lab - HOPD in Quakertown, Pennsylvania.

Dr. McCarthy's NPI, 1891369138, was assigned on May 19, 2021. Dr. McCarthy holds Pennsylvania license MT222899.

Dr. McCarthy's primary practice is St Luke's Hospital Quakertown Campus - Outpatient Respiratory Pft Lab - HOPD, at 1021 Park Ave, Quakertown, PA 18951.

Dr. McCarthy's primary practice is St Luke's Hospital Quakertown Campus - Outpatient Respiratory Pft Lab - HOPD in Quakertown, Pennsylvania. Dr. McCarthy is also affiliated with St. Luke's Hospital - Upper Bucks Campus. The medical group on file is St. Luke's South Mountain Family Practice. Dmand AI also links Dr. McCarthy to 1 more hospital, 1 dialysis center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McCarthy practices, 5 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. McCarthy's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. McCarthy is licensed in Pennsylvania.

CMS data shows 48 Medicare services from Dr. McCarthy across 1 procedure code in 2024, for 30 Medicare patients. Medicare paid $2,895 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 30 Medicare patients who saw Dr. McCarthy in 2024. The largest group is under 65, with 19 patients. 75% of them have anxiety, and 75% have depression. 53% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McCarthy's median patient age at 64, with 58% women.

In 2024, Dr. McCarthy wrote 625 Medicare Part D claims for 49 patients. 94% of them were for generic drugs. CMS names the drug for 467 of them, across 23 drugs with 11 or more claims each, at $67,537 in total drug cost. In 2023, CMS named 109 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. McCarthy for performance year 2024, reported through an alternative payment model (APM). Dr. McCarthy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McCarthy as offering telehealth.

CMS Open Payments shows 16 general payments to Dr. McCarthy from 6 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $749.